An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Clinical trial NCT07680582 · RECRUITING
Trial details
- NCT number
- NCT07680582
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-09
- Primary completion
- 2028-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.